Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1993-7-22
|
pubmed:abstractText |
This study examines the influence of the serotonergic system on the effect of metoclopramide on gastric emptying. Six subjects received the following pretreatments before metoclopramide and paracetamol: fluoxetine (5-HT uptake inhibitor); meterogoline (5-HT1 antagonist); pizotifen (5-HT2 antagonist) or methysergide (5-HT1 and 5-HT2 antagonist). One regimen consisted of metoclopramide (5-HT3 antagonist and 5-HT4 agonist) alone. Gastric emptying was measured by the mean cumulative fraction absorbed-time profiles of paracetamol. Methysergide/metoclopramide significantly delayed gastric emptying from 30 min onwards. Metoclopramide with either metergoline or pizotifen did not retard gastric emptying to the same extent, suggesting a greater influence with simultaneous 5-HT1 and 5HT2 blockade. Metoclopramide/fluoxetine caused a significant decrease in the fractional absorption of paracetamol at 5 min when compared to the metoclopramide regimen. It was assumed that the influence of metoclopramide was not optimal at this stage, therefore possibly indicating domination of 5-HT3 over 5-HT4 effects, resulting in gastric delay. It therefore seems as if all the 5-HT receptors present in the gut have a role to play in the control of gastric emptying.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Acetaminophen,
http://linkedlifedata.com/resource/pubmed/chemical/Fluoxetine,
http://linkedlifedata.com/resource/pubmed/chemical/Metergoline,
http://linkedlifedata.com/resource/pubmed/chemical/Methysergide,
http://linkedlifedata.com/resource/pubmed/chemical/Metoclopramide,
http://linkedlifedata.com/resource/pubmed/chemical/Pizotyline,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Serotonin,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0012-2823
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
54
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
40-3
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8513986-Acetaminophen,
pubmed-meshheading:8513986-Adult,
pubmed-meshheading:8513986-Fluoxetine,
pubmed-meshheading:8513986-Gastric Emptying,
pubmed-meshheading:8513986-Humans,
pubmed-meshheading:8513986-Male,
pubmed-meshheading:8513986-Metergoline,
pubmed-meshheading:8513986-Methysergide,
pubmed-meshheading:8513986-Metoclopramide,
pubmed-meshheading:8513986-Pizotyline,
pubmed-meshheading:8513986-Premedication,
pubmed-meshheading:8513986-Receptors, Serotonin,
pubmed-meshheading:8513986-Serotonin,
pubmed-meshheading:8513986-Single-Blind Method,
pubmed-meshheading:8513986-Time Factors
|
pubmed:year |
1993
|
pubmed:articleTitle |
Effects of enhancement and antagonism of 5-hydroxytryptamine activity on the influence of metoclopramide on gastric emptying.
|
pubmed:affiliation |
Department of Pharmacology, University of Pretoria, South Africa.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|